BUY IPCA Laboratories Limited — Vikas Sethi, Sethi Finmart

Entry₹1,960Inferred
Target₹2,300
Total upside +17.35%
Stop loss₹1,800-8.16% risk
CMP₹1,938.43h ago
Active-1.10%+18.65%upside left 12 mo left

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 8 Oct, 7:53 pm IST
21 supporting4 neutral6 opposing
Supports the BUY call (21)

Ipca Laboratories stock reports stronger Q1 growth as guidance rises

NewsGoogle News·7 Oct · yesterday

(opens in new tab)

Long-term trend bullish — 200-day average rising over the past quarter

Technicals · trend·7 Oct · yesterday

2 advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · adjacent horizon·5 Oct · 3d ago

Ipca Laboratories Reports Strong Q3FY26 Results with 11% Revenue Growth

NewsGoogle News·20 Sept · 3w ago

(opens in new tab)

Ipca Labs Rallies 50% on Q1 Growth; Analysts Flag Valuation Limits

NewsGoogle News·16 Sept · 3w ago

(opens in new tab)
Neutral / worth noting (4)

Nothing found in this tip’s window yet.

Weighs against the BUY call (6)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.